首页> 美国卫生研究院文献>Disease Markers >Altered β-Amyloid Precursor Protein Isoforms in Mexican Alzheimer’s Disease Patients
【2h】

Altered β-Amyloid Precursor Protein Isoforms in Mexican Alzheimer’s Disease Patients

机译:墨西哥阿尔茨海默氏病患者的β-淀粉样蛋白前体蛋白亚型改变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: To determine the β-amyloid precursor protein (βAPP) isoforms ratio as a risk factor for Alzheimer’s Disease and to assess its relationship with demographic and genetic variables of the disease. Methods: Blood samples from 26 patients fulfilling NINCDS-ADRDA diagnostic criteria for AD and 46 healthy control subjects were collected for Western blotting for βAPP. A ratio of βAPP isoforms, in optical densities, between the upper band (130 Kd) and the lower bands (106–110 Kd) was obtained. Odds ratios were obtained to determine risk factor of this component. Results: βAPP ratio on AD subjects was lower than that of control subjects: 0.3662 ± 0.1891 vs. 0.6769 ± 0.1021 (mean ± SD, p<0.05). A low βAPP ratio (<0.6) showed an OR of 4.63 (95% CI 1.45 ± 15.33). When onset of disease was taken into account, a βAPP ratio on EOAD subjects of 0.3965 ± 0.1916 was found vs. 0.3445 ± 0.1965 on LOAD subjects (p>0.05). Conclusions: Altered βAPP isoforms is a high risk factor for Alzheimer’s disease, although it has no influence on the time of onset of the disease.
机译:目的:确定β-淀粉样蛋白前体蛋白(βAPP)同种型比率作为阿尔茨海默氏病的危险因素,并评估其与该疾病的人口统计学和遗传变量的关系。方法:收集26位符合NINCDS-ADRDA AD诊断标准的患者和46位健康对照受试者的血样,进行βAPP的Western印迹分析。获得了上层带(130 Kd)和下层带(106-110 Kd)之间的βAPP同工型的光密度比。获得几率以确定该组分的危险因素。结果:AD受试者的βAPP比值比对照组低:0.3662±0.1891与0.6769±0.1021(平均值±SD,p <0.05)。低的βAPP比(<0.6)显示OR为4.63(95%CI 1.45±15.33)。考虑到疾病的发作,EOAD受试者的βAPP比为0.3965±0.1916,而LOAD受试者为0.3445±0.1965(p> 0.05)。结论:改变的βAPP同工型是阿尔茨海默氏病的高危因素,尽管它对疾病的发作时间没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号